Peek into the Process

A series of articles in the Journal of the American Medical Association this week examines the US Food and Drug Administration's approval process.

One paper from a Yale University School of Medicine-based group looks at the evidence supporting FDA's decisions to approve nearly 190 drugs between 2005 and 2012. Joseph Ross, an assistant professor of medicine at Yale, and his colleagues report that the clinical trial evidence justifying each approval varies in quality.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.